Distress: Assessing the effects of coping with cancer

Share this article:
Distress: Assessing the effects of coping with cancer
Distress: Assessing the effects of coping with cancer

Cancer has been known for many years as a stressful diagnosis that can challenge successful treatment of the disease. Screening for distress suggests that 40% to 50% of adults with cancer treated in the outpatient setting experience significantly high levels of distress that interferes with their decision-making skills and adherence to treatment protocols and schedules.1-4

A panel group was established to investigate the issues surrounding the distress incurred with a diagnosis of cancer and its treatment, and in 1999, the National Comprehensive Cancer Network (NCCN) developed clinical guidelines for distress management in the cancer patient.5 These guidelines are reviewed and updated annually, with recommendations for implementation in a variety of settings. Although widely recognized as a standard from which to benchmark quality measures, the NCCN guidelines remain just that—guidelines. Despite being an important indicator on how a patient may respond during treatment, a standard implementation mechanism for utilizing the guidelines in most oncology practices has not been established. The NCCN guidelines encompass the stages of disease, patient care settings, and institutional services and policies.6 The guidelines' major recommendations can be described as follows.

Patients should be monitored for distress. The level and nature of a patient's distress should be identified and treated promptly. Recognition and documentation processes for distress should be a part of patient care at all stages of the disease in all clinical settings.

Distress screening should be performed at the initial visit and at appropriate intervals during treatment. In addition, screening should be performed when clinically indicated, especially when disease status has changed.

Distress assessment and management should follow established clinical practice guidelines. The NCCN recommends that institutions develop interdisciplinary committees to implement the standards of care outlined by its guidelines.

Oncology care providers need knowledge and skills in assessing and managing patient distress. Education and training programs should be developed to ensure clinicians can acquire these skills.

Institutions should have licensed mental health care professionals and certified chaplains readily available. Reimbursement for mental health care should be included in medical care contracts with third party payers.

Patients and their families should be informed that distress management is an integral part of total cancer care. Treatment teams should be concerned with assessing patients' distress levels.

Assessment of the psychosocial domain should be included in clinical health outcomes measurements. Continuous quality improvement projects should include distress management programs/services provided by the institution.

MEASURING DISTRESS

Nurses are in a unique position to make a difference in screening for and management of the distress that patients often experience but may not report. More patients are seen by nurses at each visit than by physicians, especially those patients undergoing frequent chemotherapy or daily radiation treatments; therefore, nurses are at the forefront for asking the patient pertinent questions regarding symptoms of distress (ie, sleep disturbances, eating disorders, fatigue, feelings of hopelessness or anxiety) he or she may be experiencing. Patients can rate their distress with a distress thermometer, which is a simple tool that works similar to self-rating pain on a scale of 1 to 10. A more formal and involved questionnaire can be used to follow up this initial assessment if specific areas of distress need to be identified.7,8

Screening for distress should begin at the point of first contact with the patient, usually at diagnosis. A distress thermometer allows nurses to very quickly identify issues in most patients; however, a quick assessment does have its drawbacks. A distress thermometer can only indicate that distress levels are elevated as perceived by the patient using the tool; it cannot clearly identify the issues causing the patient distress. In some cases, family members are also asked to rate the patient's distress level. A comparison of the family member's report and the patient's self-report may provide a more accurate assessment of the level of distress the patient is experiencing.

POST PRIMARY CANCER CARE

Follow-up can be achieved in many ways after an elevated distress rating is identified. Most patients are referred back to their physicians, and the nurse notifies the patient's doctor of possible issues to follow up. In addition, a referral to a social worker, support group, or mental health professional may be given depending on which support services are available within the practice or service setting. The National Cancer Institute (NCI) recommends including social work, mental health professionals (psychology and psychiatry as needed), palliative care, and pastoral care in follow-up care after primary oncology care.9

Standardized follow-up assessment at subsequent visits should also be part of the nurses' responsibilities. Using the same tool for reassessment allows patient responses to be standardized, and interventional evaluations and continuous quality improvements are easier to correlate. Standard points along the continuum of care routinely considered ideal for reassessment are when treatment modalities change (surgery, radiation, and chemotherapy), at posttreatment and remission, at recurrence and palliative care, and survivorship.9 Whether patient reassessment involves one nurse or a series of nurses can be an issue, especially when the patient moves from one practice setting to another. But if the oncology team agrees that this assessment is needed, the information should be shared from setting to setting, thus standardizing care and (hopefully) maximizing treatment outcomes as well as patient and family satisfaction.

CONCLUSION

Implementation of distress measurement practices in cancer care's time has come. Instituting this practice in all care settings—private practice, as well as in-patient and out-patient units—will not be easy to accomplish. However, by agreeing to complete assessments along the continuum of care, utilize a standardized tool to measure distress, and have the required support services for managing identified distress and stressors, oncology care providers will better serve their patients. Nurses who know how to use the distress measurement tool can be the mechanism that integrates this practice into standard care. ONA


Rosemarie Tucci is oncology program manager at Lankenau Medical Center in Wynnewood, Pennsylvania.
REFERENCES

1. Hofffman BM, Zevon MA, D'Arrigo MC, Cecchini TB. Screening for distress in cancer patients: The NCCN rapid-screening measure. Psychooncology. 2004;13(11):792-799.

2. Jacobsen PB, Donovan KA, Trask PC, et al. Screening for psychologic distress in ambulatory cancer patients. Cancer. 2005;103(7):1494-1502.

3. Trask PC, Paterson A, Riba M, et al. Assessment of psychological distress in prospective bone marrow transplant patients. Bone Marrow Transplant. 2002;29(11):917-925.

4. Kennard BD, Smith SM, Olvera R, et al. Nonadherence in adolescent oncology patients: preliminary data on psychological risk factor and relationships to outcome. J Clin Psych Med Settings. 2004;11(1): 30-39.

5. NCCN practice guidelines for the management of psychosocial distress. National Comprehensive Cancer Network. Oncology (Williston Park). 1999;13(5A):113-147.

6. NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines). Dis-tress Management. Version 1.2012. http://www.nccn.org/professionals/physician_gls/pdf/distress.pdf. Accessed January 24, 2012.

7. Distress in people with cancer. American Cancer Society Web site. http://www.cancer.org/Treatment/TreatmentsandSideEffects/EmotionalSideEffects/DistressinPeoplewithCancer/index. Accessed January 24, 2012.

8. Abrahamson K. Helping patients with cancer-related distress. Oncology Times. 2010;32(8):7-8.

9. Adjustment to cancer: Anxiety and distress (PDQ) National Cancer Institute Web site. http://cancer.gov/cancertopics/pdq/supportivecare/adjustment/HealthProfessional. Accessed January 24, 2012.

Share this article:
You must be a registered member of Cancer Therapy Advisor to post a comment.
close

Next Article in Side-Effect Management

Sign Up for Free e-newsletters

CTA Community Poll

Regimen and Drug Listings

GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION

Bone Cancer Regimens Drugs
Brain Cancer Regimens Drugs
Breast Cancer Regimens Drugs
Endocrine Cancer Regimens Drugs
Gastrointestinal Cancer Regimens Drugs
Genitourinary Cancer Regimens Drugs
Gynecologic Cancer Regimens Drugs
Head and Neck Cancer Regimens Drugs
Hematologic Cancer Regimens Drugs
Lung Cancer Regimens Drugs
Other Cancers Regimens
Rare Cancers Regimens
Skin Cancer Regimens Drugs